Barry J. Regan is VP at DEXCOM INC (DXCM). They have made 11 open-market trades across 2 companies since 2019, most recently 2023-12-18.
CIK 0001746313
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $215K since 2019, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DXCM | SELL | 2023-11-08 | 2023-11-08 | $95.22 | $384K | +16.8% | +25.4% | +33.9% |
| DXCM | SELL | 2023-07-10 | 2023-07-10 | $128.05 | $509K | -0.1% | -15.1% | -36.5% |
| DXCM | SELL | 2023-04-20 | 2023-04-20 | $124.50 | $276K | -4.2% | -3.3% | +8.3% |
| DXCM | SELL | 2023-03-13 | 2023-03-14 | $106.27 | $427K | +1.8% | +3.7% | +13.2% |
| DXCM | SELL | 2023-01-30 | 2023-01-31 | $106.12 | $470K | +10.0% | +13.1% | +10.5% |
| DXCM | SELL | 2022-03-29 | 2022-03-30 | $500.00 | $553K | -5.3% | -21.4% | -42.5% |
| DXCM | SELL | 2021-12-13 | 2021-12-14 | $563.93 | $1.4M | +5.8% | -15.3% | -24.4% |
| DXCM | SELL | 2021-11-22 | 2021-11-23 | $638.65 | $1.1M | -11.1% | -3.1% | -33.7% |
| WMGI | SELL | 2020-08-17 | 2020-08-19 | $30.13 | $108K | +0.3% | +1.4% | N/A |
| WMGI | SELL | 2020-02-28 | 2020-03-02 | $30.05 | $931K | -3.9% | -7.1% | -2.0% |
| WMGI | BUY | 2019-08-13 | 2019-08-13 | $21.50 | $215K | +3.8% | +2.3% | +39.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.